细胞株Cell Lines 29-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心
- 价 格：¥19200
- 货 号：Cell Line CV29
- 产 地：北京
- BioVector NTCC典型培养物保藏中心
- 联系人：Dr.Xu, Biovector NTCC Inc.
电话：400-800-2947 工作QQ:1843439339 (微信同号)
邮件：Biovector@163.com
手机：18901268599
地址：北京
- 已注册
细胞株Cell Lines
BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心
Email:biovector@163.com
ID HEK293 eGFP-TSHZ1
AC CVCL_HC96
DR ENCODE; ENCBS351LOZ
DR ENCODE; ENCBS429FXL
CC Transfected with: HGNC; 10669; TSHZ1.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 =EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-WT1
AC CVCL_HC97
DR ENCODE; ENCBS740TWL
DR ENCODE; ENCBS927FFT
CC Transfected with: HGNC; 12796; WT1.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 =EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-ZBTB1
AC CVCL_HC98
DR ENCODE; ENCBS221WVG
DR ENCODE; ENCBS255RNI
CC Transfected with: HGNC; 20259; ZBTB1.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 =EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-ZBTB11
AC CVCL_HC99
DR ENCODE; ENCBS097DHX
DR ENCODE; ENCBS310DWJ
CC Transfected with: HGNC; 16740; ZBTB11.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 =EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-ZBTB49
AC CVCL_HD00
DR ENCODE; ENCBS652OCL
DR ENCODE; ENCBS876NMZ
CC Transfected with: HGNC; 19883; ZBTB49.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 =EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-ZBTB7A
AC CVCL_HD01
DR ENCODE; ENCBS241SWW
DR ENCODE; ENCBS628NYX
CC Transfected with: HGNC; 18078; ZBTB7A.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 =EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-ZBTB8A
AC CVCL_HD02
DR ENCODE; ENCBS078UYW
DR ENCODE; ENCBS218CJM
CC Transfected with: HGNC; 24172; ZBTB8A.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 =EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-ZEB1
AC CVCL_HD03
DR ENCODE; ENCBS073ZEX
DR ENCODE; ENCBS472JNF
CC Transfected with: HGNC; 11642; ZEB1.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 =EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-ZEB2
AC CVCL_HD04
DR ENCODE; ENCBS665JKR
DR ENCODE; ENCBS768DUW
CC Transfected with: HGNC; 14881; ZEB2.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 =EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-ZFP3
AC CVCL_HD05
DR ENCODE; ENCBS232OEE
DR ENCODE; ENCBS543JVF
CC Transfected with: HGNC; 12861; ZFP3.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 =EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-ZFP41
AC CVCL_HD06
DR ENCODE; ENCBS424AYE
DR ENCODE; ENCBS503YOP
CC Transfected with: HGNC; 26786; ZFP41.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 =EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-ZFP62
AC CVCL_HD07
DR ENCODE; ENCBS584YDT
CC Transfected with: HGNC; 23241; ZFP62.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 =EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-ZFP64
AC CVCL_HD08
DR ENCODE; ENCBS307QUS
DR ENCODE; ENCBS502HSC
CC Transfected with: HGNC; 15940; ZFP64.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 =EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-ZNF138
AC CVCL_HD09
DR ENCODE; ENCBS403FNN
DR ENCODE; ENCBS646GOM
CC Transfected with: HGNC; 12922; ZNF138.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 =EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-ZNF146
AC CVCL_HD10
DR ENCODE; ENCBS069ZWS
DR ENCODE; ENCBS314JHW
CC Transfected with: HGNC; 12931; ZNF146.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 =EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-ZNF16
AC CVCL_HD11
DR ENCODE; ENCBS213ZWT
DR ENCODE; ENCBS617FVO
CC Transfected with: HGNC; 12947; ZNF16.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 =EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-ZNF165
AC CVCL_HD12
DR ENCODE; ENCBS519XFO
CC Transfected with: HGNC; 12953; ZNF165.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 =EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-ZNF175
AC CVCL_HD13
DR ENCODE; ENCBS558YVE
DR ENCODE; ENCBS632ODA
CC Transfected with: HGNC; 12964; ZNF175.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 =EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-ZNF18
AC CVCL_HD14
DR ENCODE; ENCBS511ASG
DR ENCODE; ENCBS867IQP
CC Transfected with: HGNC; 12969; ZNF18.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 =EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-ZNF239
AC CVCL_HD15
DR ENCODE; ENCBS140ULK
DR ENCODE; ENCBS169OUF
CC Transfected with: HGNC; 13031; ZNF239.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 =EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-ZNF24
AC CVCL_HD16
DR ENCODE; ENCBS386RAW
DR ENCODE; ENCBS417ONA
CC Transfected with: HGNC; 13032; ZNF24.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 =EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-ZNF264
AC CVCL_HD17
DR ENCODE; ENCBS584HTL
CC Transfected with: HGNC; 13057; ZNF264.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 =EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-ZNF292
AC CVCL_HD18
DR ENCODE; ENCBS829KGK
DR ENCODE; ENCBS918UBA
CC Transfected with: HGNC; 18410; ZNF292.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 =EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-ZNF32
AC CVCL_HD19
DR ENCODE; ENCBS349GQD
CC Transfected with: HGNC; 13095; ZNF32.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 =EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-ZNF324
AC CVCL_HD20
DR ENCODE; ENCBS026LOR
DR ENCODE; ENCBS088ZVR
CC Transfected with: HGNC; 14096; ZNF324.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 =EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-ZNF335
AC CVCL_HD21
DR ENCODE; ENCBS879KEF
DR ENCODE; ENCBS967MZW
CC Transfected with: HGNC; 15807; ZNF335.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 =EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-ZNF341
AC CVCL_HD22
DR ENCODE; ENCBS015PWI
DR ENCODE; ENCBS020GOD
CC Transfected with: HGNC; 15992; ZNF341.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 =EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-ZNF354C
AC CVCL_HD23
DR ENCODE; ENCBS836GPK
DR ENCODE; ENCBS889KAG
CC Transfected with: HGNC; 16736; ZNF354C.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 =EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-ZNF391
AC CVCL_HD24
DR ENCODE; ENCBS076BVM
DR ENCODE; ENCBS813VRX
CC Transfected with: HGNC; 18779; ZNF391.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 =EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-ZNF423
AC CVCL_HD25
DR ENCODE; ENCBS519RHO
DR ENCODE; ENCBS992HKQ
CC Transfected with: HGNC; 16762; ZNF423.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 =EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-ZNF488
AC CVCL_HD26
DR ENCODE; ENCBS066RVK
DR ENCODE; ENCBS294FAI
CC Transfected with: HGNC; 23535; ZNF488.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 =EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-ZNF547
AC CVCL_HD27
DR ENCODE; ENCBS073WLU
DR ENCODE; ENCBS145GQX
CC Transfected with: HGNC; 26432; ZNF547.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 =EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-ZNF558
AC CVCL_HD28
DR ENCODE; ENCBS079QRO
DR ENCODE; ENCBS305FAK
CC Transfected with: HGNC; 26422; ZNF558.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 =EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-ZNF572
AC CVCL_HD29
DR ENCODE; ENCBS882KSU
CC Transfected with: HGNC; 26758; ZNF572.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 =EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-ZNF580
AC CVCL_HD30
DR ENCODE; ENCBS507LXF
DR ENCODE; ENCBS811AFW
CC Transfected with: HGNC; 29473; ZNF580.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 =EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-ZNF585B
AC CVCL_HD31
DR ENCODE; ENCBS284GFM
DR ENCODE; ENCBS472HLI
CC Transfected with: HGNC; 30948; ZNF585B.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 =EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-ZNF600
AC CVCL_HD32
DR ENCODE; ENCBS172MXQ
DR ENCODE; ENCBS629GNX
CC Transfected with: HGNC; 30951; ZNF600.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 =EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-ZNF610
AC CVCL_HD33
DR ENCODE; ENCBS479SVO
DR ENCODE; ENCBS494YKN
CC Transfected with: HGNC; 26687; ZNF610.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 =EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-ZNF623
AC CVCL_HD34
DR ENCODE; ENCBS163UGH
DR ENCODE; ENCBS644JET
CC Transfected with: HGNC; 29084; ZNF623.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 =EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-ZNF639
AC CVCL_HD35
DR ENCODE; ENCBS486AZC
DR ENCODE; ENCBS695IQG
CC Transfected with: HGNC; 30950; ZNF639.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 =EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-ZNF654
AC CVCL_HD36
DR ENCODE; ENCBS543KCA
DR ENCODE; ENCBS603HMT
CC Transfected with: HGNC; 25612; ZNF654.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 =EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-ZNF655
AC CVCL_HD37
DR ENCODE; ENCBS659QAK
CC Transfected with: HGNC; 30899; ZNF655.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 =EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-ZNF664
AC CVCL_HD38
DR ENCODE; ENCBS360VTQ
DR ENCODE; ENCBS449AKC
CC Transfected with: HGNC; 25406; ZNF664.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 =EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-ZNF680
AC CVCL_HD39
DR ENCODE; ENCBS789RTN
DR ENCODE; ENCBS860LMD
CC Transfected with: HGNC; 26897; ZNF680.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 =EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-ZNF697
AC CVCL_HD40
DR ENCODE; ENCBS681LEN
DR ENCODE; ENCBS879FIM
CC Transfected with: HGNC; 32034; ZNF697.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 =EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-ZNF707
AC CVCL_HD41
DR ENCODE; ENCBS249ESB
DR ENCODE; ENCBS402FLP
CC Transfected with: HGNC; 27815; ZNF707.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 =EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-ZNF76
AC CVCL_HD42
DR ENCODE; ENCBS168VCZ
DR ENCODE; ENCBS889BJN
CC Transfected with: HGNC; 13149; ZNF76.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 =EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-ZNF781
AC CVCL_HD43
DR ENCODE; ENCBS393FBB
DR ENCODE; ENCBS771HHP
CC Transfected with: HGNC; 26745; ZNF781.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 =EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-ZNF8
AC CVCL_HD44
DR ENCODE; ENCBS144HNV
DR ENCODE; ENCBS922JHS
CC Transfected with: HGNC; 13154; ZNF8.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 =EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-ZNF800
AC CVCL_HD45
DR ENCODE; ENCBS512GBG
CC Transfected with: HGNC; 27267; ZNF800.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 =EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-ZNF837
AC CVCL_HD46
DR ENCODE;ENCBS915UTY
DR ENCODE; ENCBS927IRD
CC Transfected with: HGNC; 25164; ZNF837.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 =EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-ZSCAN16
AC CVCL_HD47
DR ENCODE; ENCBS045SQX
DR ENCODE; ENCBS844SVG
CC Transfected with: HGNC; 20813; ZSCAN16.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 =EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-ZSCAN23
AC CVCL_HD48
DR ENCODE; ENCBS200HYZ
DR ENCODE; ENCBS970UWN
CC Transfected with: HGNC; 21193; ZSCAN23.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 =EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-ZSCAN4
AC CVCL_HD49
DR ENCODE; ENCBS401QNO
CC Transfected with: HGNC; 23709; ZSCAN4.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 =EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-ZSCAN5A
AC CVCL_HD50
DR ENCODE; ENCBS190VSK
DR ENCODE; ENCBS882KQI
CC Transfected with: HGNC; 23710; ZSCAN5A.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 =EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-ZXDB
AC CVCL_HD51
DR ENCODE; ENCBS206XBQ
DR ENCODE; ENCBS242RIC
CC Transfected with: HGNC; 13199; ZXDB.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 =EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 SimpleCell O-GalNAc
AC CVCL_S025
SY HEK293 SimpleCell; HEK293 SC
RX PubMed=23584533;
CC Characteristics: Cell engineered to produce only truncated GalNAc orNeuAc-alpha-2-6-GalNAc O-glycans.
CC Knockout cell: Method=ZFN; HGNC; 24338; C1GALT1C1.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID HEK293-A
AC CVCL_6910
SY HEK-293A; HEK293A; HEK 293A; 293A; QBI-HEK 293A; QBI-293A
DR BTO; BTO:0002524
WW http://www.thermofisher.com/order/catalog/product/R70507
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID HEK293-A7
AC CVCL_E149
SY HEK293-A7 RheoSwitch
WW http://66.155.211.155/nebecomm/products_Intl/protocolProductC2002.asp
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID HEK293-EBNA
AC CVCL_6974
AS CVCL_6350
SY 293 c18; 293c18; HEK 293 c18; HEK-293 c18; HEK293-EBNA1; HEK-293-EBNA;HEK 293-EBNA; HEK 293 EBNA; HEK293EBNA; 293 EBNA; 293-EBNA1; 293-EBNA;293/EBNA; 293EBNA; EBNA-293; EBNA293; 293E; HEK293E; HEK/EBNA; HEK-EBNA;HEK.EBNA; 293/EBNA-1
DR BTO; BTO:0002974
DR CLO; CLO_0001231
DR ATCC; CRL-10852
DR CCRID; 3111C0001CCC000152
DR TOKU-E; 242
DR TOKU-E; 3609
DR TOKU-E; 3672
RX PubMed=21356792;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/2/cell-lines-detail-131.html
CC Characteristics: The use of recombinant protein expression vectorscontaining the EBV oriP in cell lines stably expressing EBV's EBNA1 proteinsignificantly increases recombinant protein yield.
CC Transfected with: UniProtKB; P03211; EBV EBNA1.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 12,14
ST D16S539: 9
ST D5S818: 8,9
ST D7S820: 11,12
ST TH01: 7,9.3
ST TPOX: 11
ST vWA: 16,19
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID HEK293-EBNA1-6E
AC CVCL_HF20
SY HEK 293EBNA1-6E; HEK293-6E; 293-6E; 293FEt-clone 6E
RX Patent=US8551774;
RX PubMed=21356792;
WW http://www.nrc-cnrc.gc.ca/eng/solutions/licensing/10894.html
CC Registration: International Depositary Authority, IDA of Canada (IDAC);150305-01.
CC Characteristics: The use of recombinant protein expression vectorscontaining the EBV oriP in cell lines stably expressing EBV's EBNA1 proteinsignificantly increases recombinant protein yield.
CC Characteristics: This cell line is transfected with EBNA1t, a truncatedversion of EBV EBNA1 lacking the Gly-Gly-Ala repeats region. It has an enhancedability to produce recombinant protein compared to HEK293-EBNA (CVCL_6974).
CC Transfected with: UniProtKB; P03211; EBV EBNA1 (with del 101-324;EBNA1t).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6642 ! HEK293-F
SX Female
CA Transformed cell line
//
ID HEK293-EPHB1
AC CVCL_EP72
SY Ephrin-B1+
DR PRIDE; PRD000814
RX PubMed=20007894;
CC Transfected with: HGNC; 3392; EPHB1.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID HEK293-EPHB2
AC CVCL_EP73
SY EphB2+
DR PRIDE; PRD000814
RX PubMed=20007894;
CC Transfected with: HGNC; 3393; EPHB2.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID HEK293-ET
AC CVCL_6996
SY HEK-293ET; HEK293ET; HEK293 ET; HEK 293 ET; 293ET
DR BTO; BTO:0005548
DR CCRID; 3111C0001CCC000153
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID HEK293-F
AC CVCL_6642
SY HEK-293-F; HEK 293-F; HEK-293F; HEK293F; 293-F; 293 F; 293F
DR BTO; BTO:0003032
WW http://www.thermofisher.com/order/catalog/product/11625019
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/2/cell-lines-detail-29.html
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID HEK293-FT
AC CVCL_6911
SY HEK-293FT; HEK 293FT; HEK-293-FT; HEK293FT; 293-FT; 293FT; FT-293
DR BTO; BTO:0005029
DR CCRID; 3111C0001CCC000364
DR PRIDE; PXD000834
WW http://www.thermofisher.com/order/catalog/product/R70007
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606;! Homo sapiens
HI CVCL_6642 ! HEK293-F
SX Female
CA Transformed cell line
//
ID HEK293-H
AC CVCL_6643
SY HEK-293-H; HEK 293-H; HEK-293H; 293-H; 293 H; 293H
DR BTO; BTO:0003033
DR EFO; EFO_0001183
DR TOKU-E; 3991
WW http://www.thermofisher.com/order/catalog/product/11631017
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/2/cell-lines-detail-608.html
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID HEK293-Nav 1.3
AC CVCL_5I43
SY NaV 1.3 HEK
RX PubMed=11487618;
CC Transfected with: RGD; 3635; Scn3a.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID HEK293-RyR1
AC CVCL_0P75
SY HEK-RyR1
RX PubMed=24972488;
WW https://www.kerafast.com/product/1926/ryr1-expressing-hek293-cell-line
CC Transfected with: UniProtKB; P11716; Rabbit RYR1.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U421 ! Flp-In-293
SX Female
CA Transformed cell line
//
ID HEK293/5-HT2C
AC CVCL_H513
WW http://www.genscript.com/molecule/M00319-5-HT2C.ht
CC Transfected with: HGNC; 5295; HTR2C.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID HEK293/AT1
AC CVCL_H514
WW http://www.genscript.com/molecule/M00458-AT1.html
CC Transfected with: HGNC; 336; AGTR1.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID HEK293/GCGR/Galpha15
AC CVCL_H515
WW http://www.genscript.com/molecule/M00422-GCGR.html
CC Transfected with: HGNC; 4192; GCGR.
CC Transfected with: HGNC; 4383; GNA15.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID HEK293/GFP-DFCP1
AC CVCL_5A22
SY 201 cells
RX PubMed=18725538;
CC Transfected with: HGNC; 13180; ZFYVE1.
CC Transfected with: UniProtKB; P42212; GFP.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
CC Misspelling: Occasionally 'HEK293A/GFP-DFCP1'. Note: these cells are notderived from HEK293-A (personal communication from Ktistakis N.).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID HEK293/hERG
AC CVCL_H516
WW http://www.genscript.com/catalog_cell_lines.html
CC Transfected with: HGNC; 6251; KCNH2.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID HEK293/hKv1.5
AC CVCL_H517
WW http://www.genscript.com/catalog_cell_lines.html
CC Transfected with: HGNC; 6224; KCNA5.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID HEK293/hKv4.2
AC CVCL_H518
WW http://www.genscript.com/catalog_cell_lines.html
CC Transfected with: HGNC; 6238; KCND2.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID HEK293/hNav1.5
AC CVCL_H519
WW http://www.genscript.com/catalog_cell_lines.html
CC Transfected with: HGNC; 10593; SCN5A.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID HEK293/hNav1.7
AC CVCL_H520
WW http://www.genscript.com/catalog_cell_lines.html
CC Transfected with: HGNC; 10597; SCN9A.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID HEK293A mRFP-ATG9
AC CVCL_W349
SY HEK293A mRFP-Atg9; 293/mRFP-Atg9
DR Ximbio; 151828
RX PubMed=22456507;
CC Transfected with: HGNC; 22408; ATG9A.
CC Transfected with: UniProtKB; Q9U6Y8; RFP.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6910 ! HEK293-A
SX Female
CA Transformed cell line
//
ID HEK293A/GFP-LC3
AC CVCL_W347
SY HEK293A GFP-LC3; HEK293A GFP LC3; HEK293/GFP-LC3; 293/GFP-LC3
DR ECACC; 14050801
DR Ximbio; 151480
RX PubMed=16420522;
CC Transfected with: RGD; 735183; Map1lc3a.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 =EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6910 ! HEK293-A
SX Female
CA Transformed cell line
//
ID HEK293A/GFP-WIPI1
AC CVCL_5F67
DR Ximbio; 151717
CC Transfected with: HGNC; 25471; WIPI1.
CC Transfected with: UniProtKB; P42212; GFP.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606;! Homo sapiens
HI CVCL_6910 ! HEK293-A
SX Female
CA Transformed cell line
//
ID HEK293A/GFP-WIPI2
AC CVCL_5A21
DR Ximbio; 151716
CC Transfected with: HGNC; 32225; WIPI2.
CC Transfected with: UniProtKB; P42212; GFP.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6910 ! HEK293-A
SX Female
CA Transformed cell line
//
ID HEK293L
AC CVCL_M775
SY 293L
DR NIH-ARP; 3553-138
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID HEK293S
AC CVCL_A784
SY 293S
DR BioSamples; SAMEA2168959
RX PubMed=8876162;
RX PubMed=10736692;
RX PubMed=25182477;
WW http://hek293genome.org/v2/
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/2/cell-lines-detail-42.html
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
CC Omics: Genome sequenced.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID HEK293S GnTI-
AC CVCL_A785
SY 293SGnTI(-)
DR ATCC; CRL-3022
RX PubMed=12370423;
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO:11,12
ST D13S317: 12,14
ST D16S539: 9
ST D5S818: 8,9
ST D7S820: 11,12
ST TH01: 7,9.3
ST TPOX: 11
ST vWA: 16,19
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_A784 ! HEK293S
SX Female
CA Transformed cell line
//
ID HEK293SF
AC CVCL_4V94
SY 293SF
RX PubMed=10099373;
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_A784 ! HEK293S
SX Female
CA Transformed cell line
//
ID HEK293SF-3F6
AC CVCL_4V95
SY HEK 293SF-3F6; 293SF-3F6
DR ATCC; CRL-12585
RX Patent=US6210922;
RX PubMed=10099373;
WW http://www.nrc-cnrc.gc.ca/eng/solutions/licensing/10894.html
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
CC Discontinued: ATCC; CRL-12585; true.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4V94 ! HEK293SF
SX Female
CA Transformed cell line
//
ID HEK293SF-PacLV
AC CVCL_4V99
SY HEK 293 SF-PacLV; 293SF-PacLV; 293SFPacLV
RX PubMed=18180776;
CC Group: Retrovirus packaging cell line.
CC Transfected with: UniProtKB; O33453; P.putidacymR.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4V94 ! HEK293SF
SX Female
CA Transformed cell line
//
ID HEK293T
AC CVCL_0063
SY Hek293T; HEK-293T; HEK 293T; HEK-293-T; HEK 293 T; 293-T; 293 T; 293T;Human Embryonic Kidney 293T; 293tsA1609neo
DR BTO; BTO:0002181
DR CLO; CLO_0050894
DR EFO; EFO_0001082
DR EFO; EFO_0001184
DR CLDB; cl7154
DR ATCC; CRL-3216
DR BioSample; SAMN01821609
DR BioSample; SAMN03473454
DR BioSamples; SAMEA2168958
DR BioSamples; SAMEA2536418
DR BioSamples; SAMEA2536419
DR CCRID; 3111C0001CCC000091
DR CCRID; 3131C0001000200017
DR Cosmic; 1326280
DR Cosmic; 2440479
DR DSMZ; ACC-635
DR ECACC; 12022001
DR ENCODE; ENCBS634AAA
DR GEO; GSM1008573
DR ICLC; HTL04001
DR KCB; KCB 200744YJ
DR Lonza; 504
DR NCBI_Iran; C498
DR NCBI_Iran; C644
DR PRIDE; PXD000593
DR PRIDE; PXD001062
DR PRIDE; PXD001165
DR PRIDE; PXD001609
DR RCB; RCB2202
DR TOKU-E; 3537
DR Wikidata; Q27546876
RX PubMed=3031469;
RX PubMed=25182477;
RX PubMed=28196595;
WW https://en.wikipedia.org/wiki/293T
WW http://genome.ucsc.edu/ENCODE/protocols/cell/human/HEK293T_Crawford_protocol.pdf
WW http://hek293genome.org/v2/
WW http://www.addexbio.com/productdetail?pid=445
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/2/cell-lines-detail-153.html
WW https://www.fishersci.com/shop/products/hek293t-cell-line-hcl4517/nc0260915
WW http://tcpaportal.org/mclp/
CC Part of: ENCODE project common cell types; tier 3.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: ~24-30 hours (DSMZ).
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA].
CC Omics: Genome sequenced.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Misspelling: Occasionally 'HECK293T'.
ST Source(s): ATCC; DSMZ; ECACC; RCB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 12,14 (ATCC; DSMZ; RCB)
ST D13S317: 12 (ECACC)
ST D16S539: 9,13
ST D5S818: 8,9
ST D7S820: 11
ST TH01: 7,9.3
ST TPOX: 11
ST vWA: 16,19
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID HEK293T/17
AC CVCL_1926
SY HEK 293T/17; 293T/17
DR CLO; CLO_0001235
DR ATCC; CRL-11268
DR BioSample; SAMN03471332
DR CCRID; 3111C0001CCC000212
DR TOKU-E; 245
DR Wikidata; Q28178058
RX Patent=WO1994019478A1;
RX PubMed=7690960;
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA].
CC Misspelling: Occasionally '293/17'.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 12,14
ST D16S539: 9,13
ST D5S818: 8,9
ST D7S820: 11
ST TH01: 7,9.3
ST TPOX: 11
ST vWA: 16,18,19
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0063 ! HEK293T
SX Female
CA Transformed cell line
//
ID HEK293T/17 SF
AC CVCL_4V93
SY HEK 293T/17 SF; 293T/17 SF
DR ATCC; ACS-4500
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA].
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 12,14
ST D16S539: 9,13
ST D7S820: 11
ST TH01: 7,9.3
ST TPOX: 11
ST vWA: 16,19
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1926 ! HEK293T/17
SX Female
CA Transformed cell line
//
ID HEK293T(DMT1)
AC CVCL_HA71
RX PubMed=16984886;
WW https://www.kerafast.com/product/2953/dmt1-expressing-hek293-cell-line
CC Transfected with: HGNC; 10908; SLC11A2.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA].
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0063 ! HEK293T
SX Female
CA Transformed cell line
//
ID HEKR1
AC CVCL_HB83
WW https://www.kerafast.com/product/2962/ip3r-expressing-hek-293-cell-lines
CC Knockout cell: Method=CRISPR/Cas9; HGNC; 6181; ITPR2.
CC Knockout cell: Method=CRISPR/Cas9; HGNC;6182; ITPR3.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID HEKR2
AC CVCL_HB84
WW https://www.kerafast.com/product/2962/ip3r-expressing-hek-293-cell-lines
CC Knockout cell: Method=CRISPR/Cas9; HGNC; 6180; ITPR1.
CC Knockout cell: Method=CRISPR/Cas9; HGNC; 6182; ITPR3.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID HEKR2R1
AC CVCL_HB85
WW https://www.kerafast.com/product/2962/ip3r-expressing-hek-293-cell-lines
CC Knockout cell: Method=CRISPR/Cas9; HGNC; 6180; ITPR1.
CC Knockout cell: Method=CRISPR/Cas9; HGNC; 6181; ITPR2.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID HEKR2R3
AC CVCL_HB86
WW https://www.kerafast.com/product/2962/ip3r-expressing-hek-293-cell-lines
CC Knockout cell: Method=CRISPR/Cas9; HGNC; 6181; ITPR2.
CC Knockout cell: Method=CRISPR/Cas9; HGNC; 6182; ITPR3.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID HEKR3
AC CVCL_HB87
WW https://www.kerafast.com/product/2962/ip3r-expressing-hek-293-cell-lines
CC Knockout cell: Method=CRISPR/Cas9; HGNC; 6182; ITPR3.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID HEKR3R1
AC CVCL_HB88
WW https://www.kerafast.com/product/2962/ip3r-expressing-hek-293-cell-lines
CC Knockout cell: Method=CRISPR/Cas9; HGNC; 6180; ITPR1.
CC Knockout cell: Method=CRISPR/Cas9; HGNC; 6182; ITPR3.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID HEL
AC CVCL_0001
SY Hel; GM06141
DR BTO; BTO:0000565
DR CLO; CLO_0003679
DR CLO; CLO_0023565
DR EFO; EFO_0006579
DR MCCL; MCC:0000187
DR CLDB; cl0
DR CLDB; cl1585
DR BioSample; SAMN03471056
DR BioSample; SAMN03472269
DR CCLE; HEL_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR CCRID; 3131C0001000700071
DR CCRID; 3142C0001000000070
DR ChEMBL-Cells; CHEMBL3308090
DR ChEMBL-Targets; CHEMBL613888
DR Coriell; GM06141
DR Cosmic; 787432
DR Cosmic; 798663
DR Cosmic; 907053
DR Cosmic; 919128
DR Cosmic; 924040
DR Cosmic; 975251
DR Cosmic; 976722
DR Cosmic; 994176
DR Cosmic; 996314
DR Cosmic; 1012051
DR Cosmic; 1013868
DR Cosmic; 1037665
DR Cosmic; 1070698
DR Cosmic; 1078733
DR Cosmic; 1122162
DR Cosmic; 1127268
DR Cosmic; 1139508
DR Cosmic; 1139638
DR Cosmic; 1140092
DR Cosmic; 1151879
DR Cosmic; 1168467
DR Cosmic; 1170892
DR Cosmic; 1171333
DR Cosmic; 1176583
DR Cosmic; 1191710
DR Cosmic; 1192825
DR Cosmic; 1601067
DR Cosmic; 1633512
DR Cosmic; 1943609
DR Cosmic; 2089667
DR Cosmic; 2131538
DR Cosmic; 2306207
DR Cosmic-CLP; 907053
DR DSMZ; ACC-11
DR GDSC; 907053
DR GEO; GSM482506
DR GEO; GSM887077
DR GEO; GSM888147
DR GEO; GSM1028243
DR GEO; GSM1669874
DR JCRB; JCRB0062
DR KCB; KCB 200808YJ
RX PubMed=6177045;
RX PubMed=9290701;
RX PubMed=9738977;
RX PubMed=11021758;
RX PubMed=16408098;
RX PubMed=22460905;
RX PubMed=23955599;
RX PubMed=25485619;
RX PubMed=27397505;
WW http://www.proteinatlas.org/learn/cellines
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-346.html
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~36 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep antibody staining analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; COG; DSMZ; JCRB PubMed=25877200
ST Amelogenin: X,Y (COG; PubMed=25877200)
ST Amelogenin: X (Cosmic-CLP; DSMZ; JCRB)
ST CSF1PO: 10
ST D13S317: 9,11
ST D16S539: 11
ST D18S51: 16 (COG)
ST D18S51: 12,16 (PubMed=25877200)
ST D19S433: 11,13
ST D21S11: 29,30.2,31.2 (COG)
ST D21S11: 29,30.2 (PubMed=25877200)
ST D2S1338: 18,19
ST D3S1358: 15
ST D5S818: 11
ST D7S820: 7
ST D8S1179: 13,15
ST FGA: 22,23
ST Penta D: 11,13
ST Penta E: 13,18
ST TH01: 7
ST TPOX: 11
ST vWA: 14,17
DI NCIt; C7152; Erythroleukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HEL 12469
AC CVCL_2479
SY HEL-12469
DR CLO; CLO_0003680
DR CLDB; cl1593
DR ECACC; 94101201
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID HEL 299
AC CVCL_2480
SY HEL-299; Hel-299; Hel 299; HEL299
DR CLO; CLO_0003681
DR CLDB; cl1586
DR CLDB; cl1587
DR CLDB; cl1589
DR CLDB; cl1590
DR ATCC; CCL-137
DR BCRC; 60117
DR BioSample; SAMN03471455
DR ChEMBL-Cells; CHEMBL3308663
DR ChEMBL-Targets; CHEMBL614819
DR CLS; 300193/p812_HEL-299
DR ECACC; 87042207
DR IZSLER; BS CL 49
DR KCLB; 10137
RX PubMed=7065527;
ST Source(s): ATCC; CLS; ECACC; KCLB
ST Amelogenin: X,Y
ST CSF1PO: 7,10
ST D13S317: 11,12
ST D16S539: 10,11
ST D18S51: 14,17
ST D21S11: 28,31.6
ST D3S1358: 16
ST D5S818: 11,13
ST D7S820: 8,11
ST D8S1179: 14,15
ST FGA: 24,25
ST Penta D: 2.2,9
ST Penta E: 5,12
ST TH01: 7
ST TPOX: 8,12
ST vWA: 16
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID HEL 92.1.7
AC CVCL_2481
SY HEL92.1.7; HEL-92.1.7; HEL-92-1-7; HEL-92_1_7; HEL-92; HEL9217
DR BTO; BTO:0003320
DR CLO; CLO_0003682
DR CLO; CLO_0003683
DR EFO; EFO_0002193
DR CLDB; cl5067
DR CLDB; cl7132
DR ATCC; TIB-180
DR BCRC; 60370
DR BCRJ; 0308
DR CCLE; HEL9217_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR CLS; 300462/p465_HEL_9217
DR Cosmic; 683543
DR Cosmic; 976723
DR ECACC; 92111706
DR GEO; GSM887076
DR GEO; GSM888146
DR GEO; GSM1374526
DR GEO; GSM1374527
DR ICLC; HTL03002
DR IGRhCellID; HEL9217
DR Lonza; 1042
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; CLS; ECACC
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 9,11
ST D16S539: 11
ST D18S51: 12,16
ST D21S11: 29,30.2
ST D3S1358: 15
ST D5S818: 11
ST D7S820: 7
ST D8S1179: 13,15
ST FGA: 22,23
ST Penta D: 11,13
ST Penta E: 13,18
ST TH01: 7
ST TPOX: 11
ST vWA: 14,17
DI NCIt; C7152; Erythroleukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0001 ! HEL
SX Male
CA Cancer cell line
//
ID HEL-30
AC CVCL_6D72
SY Hel-30; HEL/30; HEL30; HEL
RX PubMed=383562;
RX PubMed=1711471;
RX PubMed=3144940;
RX PubMed=3597519;
RX PubMed=6190961;
CC Breed/subspecies: C3H.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Spontaneously immortalized cell line
//
ID HEL-37
AC CVCL_6D73
SY Hel-37; HEL/37
RX PubMed=1711471;
RX PubMed=3597519;
RX PubMed=6190961;
CC Breed/subspecies: C3H.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6D72 ! HEL-30
SX Female
CA Spontaneously immortalized cell line
//
ID HEL-R66
AC CVCL_1R39
DR BioSample; SAMN03152012
RX PubMed=116626;
RX PubMed=6451928;
RX PubMed=7236009;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Group: Non-human primate cell line.
CC Problematic cell line: Misidentified. Originally thought to be of humanorigin but found to be from Chlorocebus aethiops (PubMed=6451928, PubMed=7236009,PubMed=20143388).
OX NCBI_TaxID=9534; ! Chlorocebus aethiops
SX Sex undetermined
CA Undefined cell line type
//
ID HEL/TGR
AC CVCL_4Z61
RX PubMed=21976548;
CC Selected for resistance to: ChEBI; CHEBI:90304; TG101209 (N-(tert-butyl)-3-((5-methyl-2-((4-(4-methylpiperazin-1-yl)phenyl)amino)pyrimidin-4-yl)amino)benzenesulfonamide).
DI NCIt; C7152; Erythroleukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2481 ! HEL 92.1.7
SX Male
CA Cancer cell line
//
ID HEL24.3
AC CVCL_9T96
RX PubMed=26093941;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID HEL47.2
AC CVCL_9T97
RX PubMed=26096151;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID HeLa
AC CVCL_0030
SY HELA; Hela; He La; He-La; Henrietta Lacks cells; Helacyton gartleri
DR BTO; BTO:0000567
DR CLO; CLO_0003684
DR CLO; CLO_0050910
DR EFO; EFO_0001185
DR MCCL; MCC:0000219
DR CLDB; cl1594
DR CLDB; cl1595
DR CLDB; cl1596
DR CLDB; cl1597
DR CLDB; cl1599
DR CLDB; cl1600
DR CLDB; cl1601
DR CLDB; cl1603
DR ATCC; CCL-2
DR ATCC; CRM-CCL-2
DR ATCC; CRL-7923
DR BCRC; 60005
DR BCRJ; 0100
DR BioSample; SAMN03471148
DR BioSample; SAMN03472333
DR CCLV; CCLV-RIE 0082
DR CCRID; 3111C0001CCC000011
DR CCRID; 3111C0001CCC000332
DR CCRID; 3111C0002000000057
DR CCRID; 3131C0001000700019
DR CCRID; 3142C0001000000009
DR CCRID; 3153C0001000000007
DR ChEMBL-Cells; CHEMBL3308376
DR ChEMBL-Targets; CHEMBL399
DR CLS; 300194/p772_HeLa
DR Cosmic; 760219
DR Cosmic; 760490
DR Cosmic; 801357
DR Cosmic; 809231
DR Cosmic; 877477
DR Cosmic; 911999
DR Cosmic; 925354
DR Cosmic; 928907
DR Cosmic; 944113
DR Cosmic; 1019309
DR Cosmic; 1057766
DR Cosmic; 1071911
DR Cosmic; 1131525
DR Cosmic; 1193029
DR Cosmic; 1201779
DR Cosmic; 1324208
DR Cosmic; 1336880
DR Cosmic; 1571796
DR Cosmic; 2301539
DR Cosmic-CLP; 1298134
DR DSMZ; ACC-57
DR ECACC; 08011102
DR ECACC; 93021013
DR GDSC; 1298134
DR GEO; GSM113863
DR GEO; GSM226739
DR GEO; GSM226875
DR GEO; GSM253298
DR GEO; GSM436128
DR GEO; GSM436129
DR GEO; GSM723055
DR GEO; GSM723056
DR GEO; GSM1088663
DR GEO; GSM1088664
DR GEO; GSM1088665
DR GEO; GSM1088666
DR GEO; GSM1374528
DR GEO; GSM1669875
DR ICLC; HTL95023
DR IGRhCellID; HeLA
DR IZSLER; BS TCL 20
DR JCRB; JCRB9004
DR KCB; KCB 86019YJ
DR KCB; KCB 90024YJ
DR KCLB; 10002
DR LINCS; 50061
DR Lonza; 51
DR MeSH; D006367
DR NCBI_Iran; C115
DR NIH-ARP; 153-364
DR PRIDE; PXD000589
DR PRIDE; PXD000680
DR PRIDE; PXD001061
DR PRIDE; PXD001118
DR PRIDE; PXD001154
DR PRIDE; PXD001305
DR PRIDE; PXD001381
DR PRIDE; PXD001396
DR PRIDE; PXD001441
DR PRIDE; PXD001541
DR PRIDE; PXD001574
DR PRIDE; PXD001781
DR PRIDE; PXD001798
DR PRIDE; PXD001810
DR PRIDE; PXD002039
DR PRIDE; PXD002252
DR PRIDE; PXD002395
DR PRIDE; PXD002704
DR PRIDE; PXD002880
DR PRIDE; PXD003186
DR PRIDE; PXD003209
DR PRIDE; PXD003924
DR RCB; RCB0007
DR RCB; RCB3680
DR SKY/M-FISH/CGH; 5351
DR TKG; TKG 0331
DR TOKU-E; 1434
DR Wikidata; Q847482
RX CelloPub=CLPUB00047;
RX CelloPub=CLPUB00262;
RX CelloPub=CLPUB00376;
RX CelloPub=CLPUB00377;
RX DOI=10.1007/978-1-4757-1647-4_13;
RX PubMed=2990217;
RX PubMed=3028716;
RX PubMed=3371749;
RX PubMed=6935474;
RX PubMed=9892199;
RX PubMed=12001993;
RX PubMed=12661003;
RX PubMed=13052828;
RX PubMed=15302935;
RX PubMed=15531914;
RX PubMed=16589695;
RX PubMed=17311676;
RX PubMed=19722756;
RX PubMed=19941903;
RX PubMed=21269460;
RX PubMed=22068331;
RX PubMed=22278370;
RX PubMed=23336012;
RX PubMed=23925224;
RX PubMed=23925245;
RX PubMed=24618588;
RX PubMed=25485619;
RX PubMed=25894527;
RX PubMed=27397505;
RX PubMed=28196595;
WW https://en.wikipedia.org/wiki/HeLa
WW http://www.proteinatlas.org/learn/cellines
WW http://141.61.102.20/mxdb/project/show/9191407937500
WW http://micro.magnet.fsu.edu/primer/techniques/fluorescence/gallery/cells/hela/helacells.html
WW http://www.lacksfamily.net/
WW http://www.addexbio.com/productdetail?pid=44
WW http://en.vircell.com/products/hela-cell-line/
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-35.html
WW https://www.cynthiaverspaget.com/the-anarchy-cell-line
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred toATCC in 1982).
CC Characteristics: HeLa has 5 five HPV18 integration sites: three onnormal chromosomes 8 at 8q24 and two on derivative chromosomes,der(5)t(5;22;8)(qll;q11q13;q24) and der(22)t(8;22)(q24;q13).
CC Doublingtime: ~48 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (PubMed=12661003; Sanger).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC Omics: Cell surface proteome.
CC Omics: CNV analysis.
CC Omics: Deep antibody staining analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep glycome analysis.
CC Omics: Deep phosphoproteome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Genome sequenced.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Omics: Virome analysis using proteomics.
CC Anecdotal: The HeLa cell line which was established in February 1951 isthe oldest human immortal cell line.
CC Anecdotal: The fascinating story of the HeLa cell line and of HenriettaLacks from whom these cells originate are described in the book of RebeccaSkloot (CelloPub=CLPUB00377).
CC Anecdotal: The HeLa cell line and its story inspired Australian artistCynthia Verspaget to embark in 2003 on a artistic project 'The Anarchy CellLine' (TAnCL) where she mixed her blood with HeLa cells. This work laterspawned a PhD thesis (CelloPub=CLPUB00376) where among other things she makesthe observation that two main taxonomical distinctions present in the zombie,living/dead and human/nonhuman, are also present in the HeLa cell line.
CC Miscellaneous: HeLa is the most frequent contributor to cell linescontamination.
CC Discontinued: ATCC; CRL-7923; true.
ST Source(s): ATCC; CLS; Cosmic-CLP; DSMZ; ECACC; JCRB; KCLB;PubMed=11416159; PubMed=25877200; RCB; TKG
ST Amelogenin: X
ST CSF1PO: 9,10
ST D13S317: 12,13.3 (ATCC; DSMZ; JCRB; KCLB;PubMed=25877200; TKG)
ST D13S317: 13,13.3 (CLS)
ST D13S317: 12 (Cosmic-CLP; RCB)
ST D13S317: 12,14 (ECACC)
ST D16S539: 9,10
ST D18S51: 16
ST D21S11: 27 (CLS)
ST D21S11: 27,28 (PubMed=25877200)
ST D3S1358:15,18
ST D5S818: 11,12
ST D7S820: 8,12
ST D8S1179: 12,13
ST FGA: 18,21
ST Penta D: 8 (CLS)
ST Penta D: 8,15 (PubMed=25877200)
ST Penta E: 7,17
ST TH01: 7
ST TPOX: 8,12
ST vWA: 16,18
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HeLa 229
AC CVCL_1276
SY HeLa-229; HeLa229
DR BTO; BTO:0005030
DR CLO; CLO_0003685
DR CLO; CLO_0003698
DR CLDB; cl1604
DR CLDB; cl1605
DR CLDB; cl1606
DR ATCC; CCL-2.1
DR BCRC; 60290
DR CCRID; 3111C0001CCC000181
DR CCRID; 3131C0001000700020
DR ECACC; 86090201
DR IZSLER; BS TCL 21
DR JCRB; JCRB9086
DR KCLB; 10002.1
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-158.html
WW http://en.vircell.com/products/hela-229-cell-line/
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
ST Source(s): ATCC; ECACC; JCRB; KCLB
ST Amelogenin: X
ST CSF1PO: 9,10
ST D13S317: 12,13.3 (ATCC; JCRB; KCLB)
ST D13S317: 14 (ECACC)
ST D16S539: 9,10
ST D5S818: 11,12
ST D7S820: 8,12
ST TH01: 7
ST TPOX: 8,12
ST vWA: 16,18
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HeLa 382
AC CVCL_3379
DR CLO; CLO_0003686
DR CLDB; cl1607
DR CLDB; cl1608
DR ICLC; HTL95015
CC Characteristics: Control line for Hela 422 (CVCL_3380) and Hela 432(CVCL_3381); transfected with emtpy vector pBact.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HeLa 422
AC CVCL_3380
DR CLO; CLO_0003687
DR CLDB; cl1609
DR CLDB; cl1610
DR ICLC; HTL95014
CC Transfected with: HGNC; 3467; ESR1.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HeLa 432
AC CVCL_3381
DR CLO; CLO_0003688
DR CLDB; cl1611
DR CLDB; cl1612
DR ICLC; HTL95016
CC Transfected with: HGNC; 3467; ESR1 (exon 4 defective).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HeLa AG
AC CVCL_2933
DR BioSample; SAMN03471657
DR JCRB; JCRB0213
RX PubMed=9290701;
CC Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 9,10
ST D13S317: 13.3
ST D16S539: 9,10
ST D5S818: 11,12
ST D7S820: 8
ST TH01: 7
ST TPOX: 12
ST vWA: 16,18
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HeLa B
AC CVCL_2482
DR CLO; CLO_0003689
DR CLDB; cl1624
DR ECACC; 85060701
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HeLa B-50
AC CVCL_W341
SY B-50; B50
DR ATCC; CRL-12401
RX Patent=US7238526;
CC Group: Adeno-associated virus packaging cell line.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC Discontinued: ATCC; CRL-12401; true.
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HeLa BU-25
AC CVCL_2320
SY HeLa (BU-25); HeLa BU25; HeLa Bu25; HeLa/BU-25; HeLa(BU25); HeLa TK- (BU25); Bu25 TK-; BU25 TK-; Bu25TK-
DR CLO; CLO_0002050
DR CLO; CLO_0050929
DR CLDB; cl506
DR Cosmic; 753537
DR ECACC; 85022104
DR GEO; GSM827315
DR RCB; RCB0205
RX PubMed=4639815;
RX PubMed=5902315;
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine(Bromodeoxyuridine; BrdU; BUdR).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
ST Source(s): ECACC; RCB
ST Amelogenin: X
ST CSF1PO: 9,10
ST D13S317: 14
ST D16S539: 9,10
ST D5S818: 11,12
ST D7S820: 8,12
ST TH01: 7
ST TPOX: 8,12
ST vWA: 16,18
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0058 ! HeLa S3
SX Female
CA Cancer cell line
//
ID HeLa C12
AC CVCL_W342
SY C12
RX PubMed=8590738;
RX PubMed=8986439;
CC Group: Adeno-associated virus packaging cell line.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HeLa CD4-Clone 6C
AC CVCL_X634
SY HT4-6C; HeLa clone 6C
DR NIH-ARP; 459-18
RX PubMed=2293663;
CC Transfected with: HGNC; 1678; CD4.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HeLa CD4+ Clone1022
AC CVCL_U339
SY HeLa CD4+Clone1022; Clone 1022
DR CLO; CLO_0050933
DR BioSample; SAMN03471970
DR NIH-ARP; 1109-17
DR RCB; RCB2355
RX PubMed=1984477;
CC Doubling time: ~38 hours (NIH-ARP).
CC Transfected with: HGNC; 1678; CD4.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 9,10
ST D13S317: 12
ST D16S539: 9
ST D5S818: 11,12
ST D7S820: 8,12
ST TH01: 7
ST TPOX: 8,12
ST vWA: 16,18
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HeLa DH
AC CVCL_2483
DR CLO; CLO_0003690
DR ECACC; 96112022
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HeLa ICRP
AC CVCL_9T98
DR LINCS; 51102
RX PubMed=25953765;
CC Transfected with: Initiator caspase reporter protein (IC-RP); FRETdonor-acceptor pair (CFP and YFP) connected by a caspase cleavage sequence('DEVDR') linker.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HeLa ICRP Bcl-2-mCherry
AC CVCL_9T99
DR LINCS; 51105
RX PubMed=25953765;
CC Transfected with: Initiator caspase reporter protein (IC-RP); FRETdonor-acceptor pair (CFP and YFP) connected by a caspase cleavage sequence('DEVDR') linker.
CC Transfected with: HGNC; 990; BCL2.
CC Transfected with: UniProtKB; X5DSL3; mCherry fluorescent protein.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9T98 ! HeLa ICRP
SX Female
CA Cancer cell line
//
ID HeLa ICRP Bcl-XL-mCherry
AC CVCL_9U00
DR LINCS; 51106
RX PubMed=25953765;
CC Transfected with: Initiator caspase reporter protein (IC-RP); FRETdonor-acceptor pair (CFP and YFP) connected by a caspase cleavage sequence('DEVDR') linker.
CC Transfected with: HGNC; 992; BCL2L1.
CC Transfected with: UniProtKB; X5DSL3; mCherry fluorescent protein.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9T98 ! HeLa ICRP
SX Female
CA Cancer cell line
//
ID HeLa ICRP FLIP-L-mCherry
AC CVCL_9U01
DR LINCS; 51103
RX PubMed=25953765;
CC Transfected with: Initiator caspase reporter protein (IC-RP); FRETdonor-acceptor pair (CFP and YFP) connected by a caspase cleavage sequence('DEVDR') linker.
CC Transfected with: HGNC; 1876; CFLAR (isoform FLIP-L).
CC Transfected with: UniProtKB; X5DSL3; mCherry fluorescent protein.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9T98 ! HeLa ICRP
SX Female
CA Cancer cell line
//
ID HeLa ICRP FLIP-S-mCherry
AC CVCL_9U02
DR LINCS; 51104
RX PubMed=25953765;
CC Transfected with: Initiator caspase reporter protein (IC-RP); FRETdonor-acceptor pair (CFP and YFP) connected by a caspase cleavage sequence('DEVDR') linker.
CC Transfected with: HGNC; 1876; CFLAR (isoform FLIP-S).
CC Transfected with: UniProtKB; X5DSL3; mCherry fluorescent protein.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9T98 ! HeLa ICRP
SX Female
CA Cancer cell line
//
ID HeLa JW36
AC CVCL_W331
SY HeLa(JW36); HeLa (JW-36); JW 36; JW-36; JW36
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HeLa K11
AC CVCL_V312
SY K11
RX PubMed=4163412;
RX PubMed=4576519;
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HeLa K11A-HG-1
AC CVCL_V313
SY K11A-HG-1
RX PubMed=457258;
RX PubMed=4576519;
RX PubMed=5334769;
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_V312 ! HeLa K11
SX Female
CA Cancer cell line
//
ID HeLa Kyoto
AC CVCL_1922
SY HeLa-Kyoto; HeLa (Kyoto); HeLa(Kyoto); HeLa 'Kyoto'; HeLa isolate Kyoto;Hela K
DR PRIDE; PXD002987
CC From: Narumiya S.; Kyoto University; Kyoto; Japan.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HeLa Kyoto EGFP-alpha-tubulin/H2B-mCherry
AC CVCL_L802
SY HeLa H2B-mRFP and mEGFP-alpha-tubulin
DR CLS; 300670/p2191_HeLa_Kyoto_EGFP_alpha-tubulinH2B-mCherry
RX PubMed=19203582;
RX PubMed=20360735;
RX PubMed=23550136;
RX PubMed=23594443;
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 =EGFP).
CC Transfected with: UniProtKB; X5DSL3; mCherry fluorescent protein.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC Omics: Genome sequenced.
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1922 ! HeLa Kyoto
SX Female
CA Cancer cell line
//
ID HeLa Kyoto EGFP-Cap-D2
AC CVCL_1D60
SY HeLa Kyoto EGFP CAP-D2; HeLa Kyoto Cap-D2 EGFP
DR CLS; 300675/p888_HeLa_Kyoto_Cap-D2_EGFP
CC Transfected with: HGNC; 24305; NCAPD2.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 =EGFP).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1922 ! HeLa Kyoto
SX Female
CA Cancer cell line
//
ID HeLa Kyoto EGFP-EB3
AC CVCL_1D61
SY HeLa Kyoto EB3 EGFP
DR CLS; 300668/p1027_HeLa_Kyoto_EGFP-EB3
CC Transfected with: HGNC; 6892; MAPRE3.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 =EGFP).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1922 ! HeLa Kyoto
SX Female
CA Cancer cell line
//
ID HeLa Kyoto EGFP-H2B
AC CVCL_1D63
SY HeLa Kyoto H2B EGFP
DR CLS; 300673/p885_HeLa_Kyoto_EGFP-H2B
RX PubMed=19203582;
RX PubMed=20360735;
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 =EGFP).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1922 ! HeLa Kyoto
SX Female
CA Cancer cell line
//
ID HeLa Kyoto EGFP-Kleisin-beta
AC CVCL_1D64
SY HeLa Kyoto Kleisin-beta EGFP
DR CLS; 300674/p2184_HeLa_Kyoto_EGFP-Kleisin-beta
CC Transfected with: HGNC; 25071; NCAPH2.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 =EGFP).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1922 ! HeLa Kyoto
SX Female
CA Cancer cell line
//
ID HeLa Kyoto EGFP-LaminA/H2B-mCherry
AC CVCL_1D62
DR CLS; 300921/p10513_HeLa_Kyoto_EGFP-LaminAH2B-mCherry_growing
RX PubMed=22986494;
CC Transfected with: HGNC; 6636; LMNA.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 =EGFP).
CC Transfected with: UniProtKB; X5DSL3; mCherry fluorescent protein.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1922 ! HeLa Kyoto
SX Female
CA Cancer cell line
//
ID HeLa Kyoto Mad2-LAP_H2B-mCherry
AC CVCL_1D65
SY HeLa Kyoto Mad2-LAP
DR CLS; 300920/p11640_HeLa_Kyoto_Mad2-LAPH2B-mCherry
CC Transfected with: UniProtKB; P42212; GFP.
CC Transfected with: UniProtKB; X5DSL3; mCherry fluorescent protein.
CC Transfected with: MGI; MGI:1860374; Mad2l1.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1922 ! HeLa Kyoto
SX Female
CA Cancer cell line
//
ID HeLa LChm
AC CVCL_IM62
DR CLO; CLO_0003691
DR CLDB; cl1613
RX PubMed=769341;
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HeLa M
AC CVCL_R965
SY HeLa-M; HelaM
DR CLO; CLO_0003692
DR CLDB; cl1614
RX PubMed=21416529;
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HeLa NR1
AC CVCL_1277
SY HeLaNR1
DR CLO; CLO_0003693
DR ATCC; CRL-12510
DR ATCC; CRL-13011
RX Patent=US6326196;
CC Transfected with: UniProtKB; P27967; Barley nitrate reductase.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 9,10
ST D13S317: 12,13.3
ST D16S539: 9,10
ST D5S818: 11,12
ST D7S820: 8,12
ST TH01: 7
ST TPOX: 8,12
ST vWA: 16,18
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HeLa NucLight Green
AC CVCL_DF41
WW http://www.essenbioscience.com/essen-products/reagents-and-consumables/hela-nuclight-green-cells/
CC Characteristics: Stably expresses a non-perturbing nuclear restrictedgreen fluorescent label.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 =EGFP).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HeLa NucLight Red
AC CVCL_DF42
WW http://www.essenbioscience.com/essen-products/reagents-and-consumables/hela-nuclight-red-cells/
CC Characteristics: Stably expresses a non-perturbing nuclear restrictedred fluorescent label.
CC Transfected with: mKate2; a bright red fluorescent protein derived fromeqFP578.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HeLa Ohio
AC CVCL_2484
SY Ohio-HeLa
DR CLO; CLO_0003694
DR CLDB; cl1615
DR ECACC; 84121901
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/o/cell-lines-detail-105.html
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HeLa PurRII7
AC CVCL_4W41
RX PubMed=3207599;
CC Selected for resistance to: ChEBI; CHEBI:17939; Puromycin.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0058 ! HeLa S3
SX Female
CA Cancer cell line
//
ID HeLa R19
AC CVCL_M763
SY HeLa R-19; HeLa (R19)
RX PubMed=6086949;
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HeLa S3
AC CVCL_0058
SY HeLa s3; HeLa-S3; HELA-S3; HeLa/S3; HeLa.S3; HeLa S 3; HeLa S-3; HeLaS3;S3-HeLa; S3 HeLa
DR BTO; BTO:0000568
DR CLO; CLO_0003695
DR CLO; CLO_0003696
DR CLO; CLO_0003699
DR CLO; CLO_0050921
DR CLO; CLO_0050936
DR EFO; EFO_0002791
DR MCCL; MCC:0000220
DR CLDB; cl1616
DR CLDB; cl1617
DR CLDB; cl1619
DR CLDB; cl1620
DR CLDB; cl1621
DR CLDB; cl1622
DR ATCC; CCL-2.2
DR ATCC; CRL-7924
DR BCRC; 60101
DR BioSample; SAMN03472408
DR BioSample; SAMN03472767
DR CCRID; 3111C0001CCC000188
DR CCRID; 3111C0002000000009
DR CLS; 300384/p699_HeLa_S3
DR Cosmic; 846181
DR Cosmic; 1201780
DR Cosmic; 1324209
DR DSMZ; ACC-161
DR ECACC; 87110901
DR ENCODE; ENCBS031GUL
DR ENCODE; ENCBS061SJE
DR ENCODE; ENCBS075PNA
DR ENCODE; ENCBS094KYE
DR ENCODE; ENCBS113ENC
DR ENCODE; ENCBS146YHK
DR ENCODE; ENCBS163VBG
DR ENCODE; ENCBS199XIN
DR ENCODE; ENCBS229UDI
DR ENCODE; ENCBS254ZSR
DR ENCODE; ENCBS292TEU
DR ENCODE; ENCBS352IHZ
DR ENCODE; ENCBS376OKH
DR ENCODE; ENCBS417UAY
DR ENCODE; ENCBS423QWP
DR ENCODE; ENCBS424JTA
DR ENCODE; ENCBS432ENC
DR ENCODE; ENCBS434SUM
DR ENCODE; ENCBS450RLH
DR ENCODE; ENCBS468RLW
DR ENCODE; ENCBS493MKF
DR ENCODE; ENCBS500SDW
DR ENCODE; ENCBS529RSF
DR ENCODE; ENCBS575PET
DR ENCODE; ENCBS577WSP
DR ENCODE; ENCBS580FYL
DR ENCODE; ENCBS598ZWC
DR ENCODE; ENCBS635AAA
DR ENCODE; ENCBS636AAA
DR ENCODE; ENCBS637AAA
DR ENCODE; ENCBS646PGB
DR ENCODE; ENCBS647UNF
DR ENCODE; ENCBS655ARO
DR ENCODE; ENCBS658BKJ
DR ENCODE; ENCBS681BHB
DR ENCODE; ENCBS684AAA
DR ENCODE; ENCBS685AAA
DR ENCODE; ENCBS686AAA
DR ENCODE; ENCBS687AAA
DR ENCODE; ENCBS688AAA
DR ENCODE; ENCBS689AAA
DR ENCODE; ENCBS714AAA
DR ENCODE; ENCBS735AAA
DR ENCODE; ENCBS736AAA
DR ENCODE; ENCBS737AAA
DR ENCODE; ENCBS738AAA
DR ENCODE; ENCBS739AAA
DR ENCODE; ENCBS740AAA
DR ENCODE; ENCBS748HNU
DR ENCODE; ENCBS804AAA
DR ENCODE; ENCBS805AAA
DR ENCODE; ENCBS812AOY
DR ENCODE; ENCBS822AAA
DR ENCODE; ENCBS823AAA
DR ENCODE; ENCBS833ISA
DR ENCODE; ENCBS834AAA
DR ENCODE; ENCBS838AAA
DR ENCODE; ENCBS839AAA
DR ENCODE; ENCBS854BZN
DR ENCODE; ENCBS877WSH
DR ENCODE; ENCBS890POO
DR ENCODE; ENCBS899VUW
DR GEO; GSM472905
DR GEO; GSM472916
DR GEO; GSM472932
DR GEO; GSM816643
DR GEO; GSM816633
DR GEO; GSM945201
DR GEO; GSM945208
DR GEO; GSM945230
DR GEO; GSM945253
DR ICLC; HTL95020
DR IFO; IFO50011
DR IZSLER; BS TCL 22
DR JCRB; JCRB9010
DR KCLB; 10002.2
DR Lonza; 877
DR NCBI_Iran; C572
DR PRIDE; PXD000212
DR PRIDE; PXD000674
DR PRIDE; PXD000964
DR PRIDE; PXD002436
DR PRIDE; PXD003346
DR RCB; RCB0191
DR RCB; RCB1525
DR RCB; RCB3682
DR TKG; TKG 0444
DR TOKU-E; 1437
RX PubMed=9290701;
RX PubMed=13286432;
RX PubMed=23325432;
RX PubMed=23925245;
WW http://genome.ucsc.edu/ENCODE/protocols/cell/human/HeLa-S3_protocol.pdf
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-157.html
WW http://immortalcells.blogspot.ch/2011/12/hela-vs-hela-s3.html
CC Part of: ENCODE project common cell types; tier 2.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred toATCC in 1982).
CC Doubling time: ~48 hours (DSMZ).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC Omics: DNA methylation analysis.
CC Omics: Genome sequenced.
CC Omics: H3K27me3 ChIP-seq epigenome analysis.
CC Omics: H3K36me3 ChIP-seq epigenome analysis.
CC Omics: H3K4me3 ChIP-seq epigenome analysis.
CC Omics: H3K9ac ChIP-seq epigenome analysis.
CC Anecdotal: The 'S' series of Hela clones was named after Dr. FlorenceSabin.
CC Discontinued: ATCC; CRL-7924; true.
ST Source(s): ATCC; CLS; DSMZ; ECACC; JCRB; KCLB; PubMed=11416159; RCB; TKG
ST Amelogenin: X
ST CSF1PO: 9,10
ST D13S317: 13.3 (ATCC; CLS; JCRB_JCRB9010; KCLB; TKG)
ST D13S317: 12,13.3 (DSMZ; JCRB_IFO50011)
ST D13S317: 14 (ECACC)
ST D13S317: 12 (RCB)
ST D16S539: 9,10
ST D18S51: 16
ST D21S11: 27,28
ST D3S1358: 15,18
ST D5S818: 11,12 (ATCC; CLS; ECACC; JCRB_JCRB9010; KCLB; RCB; TKG)
ST D5S818: 11 (JCRB_IFO50011)
ST D7S820: 8,12 (ATCC; CLS; DSMZ; ECACC; JCRB_IFO50011; KCLB; RCB; TKG)
ST D7S820: 8 (JCRB_JCRB9010)
ST D8S1179: 12,13
ST FGA: 18,21
ST Penta D: 8,15
ST Penta E: 7,17
ST TH01: 7
ST TPOX: 8,12
ST vWA: 16,18 (ATCC; CLS; DSMZ; ECACC; KCLB; PubMed=11416159; RCB; TKG)
ST vWA: 17,18 (JCRB_IFO50011)
ST vWA: 16,17,18 (JCRB_JCRB9010)
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HeLa S3 (sc)
AC CVCL_2934
SY HeLa S3 (SC)
DR CLO; CLO_0050911
DR BioSample; SAMN03472352
DR JCRB; JCRB0713
DR RCB; RCB0271
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
ST Source(s): JCRB; RCB
ST Amelogenin: X
ST CSF1PO: 9,10
ST D13S317: 12,13.3 (JCRB)
ST D13S317: 12 (RCB)
ST D16S539: 9,10
ST D5S818: 11
ST D7S820: 8,12
ST TH01: 7
ST TPOX: 8,12
ST vWA: 17,18
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0058 ! HeLa S3
SX Female
CA Cancer cell line
//
ID HeLa S3 EGFP-alpha-tubulin/H2B-mCherry
AC CVCL_HP86
SY HeLa mCherry-Histone H2B EGFP-Alpha Tubulin
DR Ximbio; 152987
RX PubMed=21187329;
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 =EGFP).
CC Transfected with: UniProtKB; X5DSL3; mCherry fluorescent protein.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0058 ! HeLa S3
SX Female
CA Cancer cell line
//
ID HeLa S3 EGFP-H2B
AC CVCL_HP87
SY HeLa EGFP-Histone H2B
DR Ximbio; 152940
RX PubMed=21187329;
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 =EGFP).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0058 ! HeLa S3
SX Female
CA Cancer cell line
//
ID HeLa S3 mer-
AC CVCL_U209
SY HeLa.S3(Mer^(-))
DR CLO; CLO_0050914
DR RCB; RCB0503
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 9,10
ST D16S539: 9,10
ST D5S818: 11,12
ST D7S820: 8
ST TH01: 7
ST TPOX: 8,12
ST vWA: 15,18
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0058 ! HeLa S3
SX Female
CA Cancer cell line
//
ID HeLa SimpleCell O-GalNAc
AC CVCL_S026
SY HeLa SimpleCell; HeLa SC
RX PubMed=23584533;
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HeLa SS6
AC CVCL_R768
SY HeLa-SS6
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HeLa Tet-Off
AC CVCL_V352
SY HeLa Tet-off; HeLa-TO
DR TOKU-E; 4088
WW http://www.clontech.com/US/Products/Inducible_Systems/Tetracycline-Inducible_Expression/Tet-Off_Cell_Lines
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HeLa Tet-On 3G
AC CVCL_V353
WW http://www.clontech.com/US/Products/Inducible_Systems/Tetracycline-Inducible_Expression/Tet-On_3G_Cell_Lines
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HeLa TG
AC CVCL_2935
SY HeLaTG
DR CLO; CLO_0050922
DR JCRB; JCRB0214
DR RCB; RCB1891
DR TKG; TKG 0204
RX PubMed=9290701;
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine(6-thioguanine; 6-TG).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
ST Source(s): JCRB; RCB; TKG
ST Amelogenin: X
ST CSF1PO: 9,10
ST D13S317: 13.3
ST D16S539: 9,10
ST D5S818: 11,12
ST D7S820: 8
ST TH01: 7
ST TPOX: 12
ST vWA: 16,18
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HeLa TG Cap
AC CVCL_2936
DR JCRB; JCRB0215
RX PubMed=9290701;
CC Selected for resistance to: ChEBI; CHEBI:17698; Chloramphenicol.
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine(6-thioguanine; 6-TG).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 9,10
ST D13S317: 13.3
ST D16S539: 9,10
ST D5S818: 11,12
ST D7S820: 8
ST TH01: 7
ST TPOX: 12
ST vWA: 16,18
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HeLa TK-
AC CVCL_9497
DR CLO; CLO_0003697
DR CLDB; cl1623
WW http://www.rccc.cytspb.rssi.ru/ecellbank/human/hHela-TK.htm
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine(Bromodeoxyuridine; BrdU; BUdR).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HeLa tTS
AC CVCL_V354
WW http://www.clontech.com/US/Products/Inducible_Systems/Tetracycline-Inducible_Expression/Tet-tTS_Cell_Lines
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HeLa.EpoA9
AC CVCL_4Z13
RX PubMed=12467233;
CC Selected for resistance to: ChEBI; CHEBI:31549; Epothilone A (EpoA).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HeLa.EpoB1.8
AC CVCL_4Z14
RX PubMed=12467233;
CC Selected for resistance to: ChEBI; CHEBI:31550; Epothilone B (EpoB).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HeLa.P3
AC CVCL_2937
DR CLO; CLO_0050912
DR JCRB; JCRB0649
DR JCRB; JCRB0649.1
DR JCRB; NIHS0372
DR RCB; RCB0402
RX PubMed=4328993;
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC Discontinued: JCRB; NIHS0372; true.
ST Source(s): JCRB; PubMed=11416159; RCB
ST Amelogenin: X
ST CSF1PO: 9,10
ST D13S317: 12,13.3 (JCRB; PubMed=11416159)
ST D13S317: 12 (RCB)
ST D16S539: 9,10
ST D18S51: 16
ST D21S11: 27
ST D5S818: 11,12
ST D7S820: 8,12
ST D8S1179: 12,13
ST FGA: 18,21
ST TH01: 7
ST TPOX: 12
ST vWA: 16,18
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HeLa.P3(S)
AC CVCL_2938
SY HeLa.P3 (S); HeLaP3(S)
DR JCRB; JCRB0606
DR RCB; RCB3681
DR TKG; TKG 0465
RX PubMed=9290701;
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
ST Source(s): TKG
ST Amelogenin: X
ST CSF1PO: 9,10
ST D13S317: 13.3
ST D16S539: 9,10
ST D5S818: 11,12
ST D7S820: 8,12
ST TH01: 7
ST TPOX: 8,12
ST vWA: 16,18,19
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HeLa.S-Fucci
AC CVCL_E070
DR CLO; CLO_0050931
DR RCB; RCB2812
RX PubMed=18267078;
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HeLa.S-Fucci2
AC CVCL_U187
DR CLO; CLO_0050932
DR RCB; RCB2867
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HeLa/DDP
AC CVCL_C869
DR CCRID; 3142C0001000000056
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HeLa/MMTV-luc
AC CVCL_2939
DR ECACC; 11033106
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
ST Source(s): ECACC
ST Amelogenin: X
ST CSF1PO: 9,10
ST D16S539: 9,10
ST D5S818: 11,12
ST D7S820: 8,12
ST TH01: 7
ST TPOX: 8,12
ST vWA: 16,18
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HeLa/PTX
AC CVCL_HF87
RX PubMed=25015454;
CC Doubling time: 32.5 +- 2.21 hours (PubMed=25015454).
CC Selected for resistance to: ChEBI; CHEBI:45863; Paclitaxel (Taxol).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HeLa(tTA)1
AC CVCL_6E62
RX PubMed=9542626;
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HeLa-80
AC CVCL_4776
SY HeLa 80
DR BTO; BTO:0003180
RX PubMed=2770770;
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HeLa-APL
AC CVCL_9493
SY HeLa-R
RX PubMed=15365569;
RX PubMed=17338558;
CC Selected for resistance to: ChEBI; CHEBI:90205; Plitidepsin(Dehydrodidemnin B; Aplidin).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC Omics: Proteome analysis by 2D-DE/MS.
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HeLa-APOBEC3G
AC CVCL_W646
DR NIH-ARP; 9907-2
RX PubMed=14557625;
CC Transfected with: HGNC; 17357; APOBEC3G.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HeLa-CD14
AC CVCL_H339
SY Hela-CD14
RX PubMed=22741009;
RX PubMed=23086642;
CC Transfected with: HGNC; 1628; CD14.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HeLa-env-Eli
AC CVCL_1H14
RX PubMed=3265154;
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HeLa-env-IIIB
AC CVCL_1H15
RX PubMed=3265154;
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HeLa-env-Mal
AC CVCL_1H16
RX PubMed=3265154;
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HeLa-LAV
AC CVCL_S496
SY HeLa/LAV
DR NIH-ARP; 1301-445
RX PubMed=1687144;
CC Transfected with: HGNC; 1678; CD4.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_S495 ! HeLa-T4+
SX Female
CA Cancer cell line
//
ID HeLa-luc
AC CVCL_5J41
RX PubMed=10933067;
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC Discontinued: PerkinElmer; Catalog number 119272.
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HeLa-MAGI
AC CVCL_D259
SY HeLa MAGI; HeLa Magi; MAGI; HeLa-CD4-LTR-beta-gal;HeLa-CD4-LTR/beta-gal; CD4-LTR/beta-gal
DR BTO; BTO:0003588
DR CLO; CLO_0050934
DR NIH-ARP; 1470-325
DR RCB; RCB2356
RX PubMed=1548759;
CC Transfected with: HGNC; 1678; CD4.
CC Transfected with: UniProtKB; P00722; E.coli lacZ.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 9,10
ST D13S317: 12
ST D16S539: 9,10
ST D5S818: 11,12
ST D7S820: 8,12
ST TH01: 7
ST TPOX: 8,12
ST vWA: 16,18
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HeLa-MAGI-CCR5
AC CVCL_D260
SY MAGI-CCR5; MAGI-CCR-5
DR BTO; BTO:0003587
DR NIH-ARP; 3522-329
RX PubMed=9094670;
RX PubMed=9201229;
WW http://depts.washington.edu/uwc4c/webform_uploader/new/3357.pdf
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-559.html
CC Transfected with: HGNC; 1678; CD4.
CC Transfected with: HGNC; 1606; CCR5.
CC Transfected with: UniProtKB; P00722; E.coli lacZ.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D259 ! HeLa-MAGI
SX Female
CA Cancer cell line
//
ID HeLa-Mitotrap
AC CVCL_AR66
DR ECACC; 15042201
DR Ximbio; 152426
RX PubMed=20159602;
WW http://www.enterprise.cam.ac.uk/reagents/hela-mitotrap-cell-lines/
CC Characteristics: Can be used to determine the function of a protein byrapidly inactivating the protein of interest by rapamycin-induced rerouting tothe mitochondria. This process is termed 'knocksideway'.
CC Transfected with: Mitotrap; a construct composed of the import signal ofyeast TOM70, a YFP and the rapamycin-binding (FRB) domain from MTOR.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_R965 ! HeLa M
SX Female
CA Cancer cell line
//
ID HeLa-Mitotrap-Ap1g1-FKBP
AC CVCL_AR67
SY HeLa-Mitotrap Ap1g1-FKBP
DR ECACC; 15042203
DR Ximbio; 152427
RX PubMed=20159602;
WW http://www.enterprise.cam.ac.uk/reagents/hela-mitotrap-cell-lines/
CC Transfected with: Mitotrap; a construct composed of the import signal ofyeast TOM70, a YFP and the rapamycin-binding (FRB) domain from MTOR.
CC Transfected with: HGNC; 555; AP1G1 (tagged with the FKBP domain fromFKBP1A).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_AR66 ! HeLa-Mitotrap
SX Female
CA Cancer cell line
//
ID HeLa-Mitotrap-Ap2a2-FKBP
AC CVCL_AR69
DR Ximbio; 152428
RX PubMed=20159602;
WW http://www.enterprise.cam.ac.uk/reagents/hela-mitotrap-cell-lines/
CC Transfected with: Mitotrap; a construct composed of the import signal ofyeast TOM70, a YFP and the rapamycin-binding (FRB) domain from MTOR.
CC Transfected with: HGNC; 562; AP2A2 (tagged with the FKBP domain fromFKBP1A).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_AR66 ! HeLa-Mitotrap
SX Female
CA Cancer cell line
//
ID HeLa-Mitotrap-GGA2-FKBP
AC CVCL_AR70
DR Ximbio; 152429
RX PubMed=22902756;
WW http://www.enterprise.cam.ac.uk/reagents/hela-mitotrap-cell-lines/
CC Transfected with: Mitotrap; a construct composed of the import signal ofyeast TOM70, a YFP and the rapamycin-binding (FRB) domain from MTOR.
CC Transfected with: HGNC; 16064; GGA2 (tagged with the FKBP domain fromFKBP1A).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_AR66 ! HeLa-Mitotrap
SX Female
CA Cancer cell line
//
ID HeLa-Munc18b
AC CVCL_GR67
SY HeLa-Munc18b15
DR TOKU-E; 4145
RX PubMed=19723587;
CC Transfected with: HGNC; 11445; STXBP2.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HeLa-RR-B51S
AC CVCL_1J89
SY HeLa RR-B51S
DR ATCC; PTA-5258
RX Patent=US7585667;
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HeLa-T4+
AC CVCL_S495
SY HeLa T4+; HeLaT4+; Hela-T4
DR NIH-ARP; 154-253
RX PubMed=3094962;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-298.html
WW http://www.nibsc.org/Default.aspx?pageid=597&id=0019&theme=default
CC Transfected with: HGNC; 1678; CD4.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HeLa-T8+
AC CVCL_1D87
SY HeLa T8+; HeLaT8+; HeLa 8+
DR NIH-ARP; 155-254
RX PubMed=3094962;
WW http://www.nibsc.org/Default.aspx?pageid=597&id=0020&theme=default
CC Transfected with: HGNC; 1706; CD8A.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HeLa-tat-III
AC CVCL_1H25
SY HeLa-Tat-III; HeLa-tatIII
DR NIH-ARP; 502-81
RX PubMed=3265154;
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HeLa-tat-III/CMV/d1EGFP
AC CVCL_1H26
SY HeLa-Tat-III/CMV/d1EGFP
DR NIH-ARP; 11062-89
RX PubMed=15498776;
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 =EGFP).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1H25 ! HeLa-tat-III
SX Female
CA Cancer cell line
//
ID HeLa-tat-III/LTR/d1EGFP
AC CVCL_1H13
SY HeLa-Tat-III/LTR/d1EGFP
DR NIH-ARP; 11063-90
RX PubMed=15498776;
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 =EGFP).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1H25 ! HeLa-tat-III
SX Female
CA Cancer cell line
//
ID HeLa-UGT1A9
AC CVCL_9U03
RX PubMed=22071170;
CC Transfected with: HGNC; 12541; UGT1A9.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HeLa9903
AC CVCL_2485
SY HeLa 9903; Hela-9903
DR ECACC; 11033105
DR JCRB; JCRB1318
CC Transfected with: HGNC; 3467; ESR1.
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
ST Source(s): ECACC; JCRB
ST Amelogenin: X
ST CSF1PO: 9,10
ST D13S317: 12,13.3
ST D16S539: 9,10
ST D5S818: 11,12
ST D7S820: 8,12
ST TH01: 7
ST TPOX: 8,12
ST vWA: 16,18
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HeLaRC32
AC CVCL_B053
SY HeRC32
DR ATCC; CRL-2972
RX PubMed=10953917;
CC Group: Adeno-associated virus packaging cell line.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 9,10
ST D13S317: 12,13.3
ST D16S539: 9,10
ST D5S818: 11,12
ST D7S820: 8,12
ST TH01: 7
ST TPOX: 8,12
ST vWA: 16,18
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HeLaSF
AC CVCL_1278
SY HELASF
DR ATCC; CCL-2.3
DR Cosmic; 687509
DR GEO; GSM1669876
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC Omics: DNA methylation analysis.
CC Discontinued: ATCC; CCL-2.3; true.
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HELP I
AC CVCL_6D74
RX PubMed=1711471;
RX PubMed=2434329;
RX PubMed=3597519;
CC Breed/subspecies: C3H.
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_6D75 ! HELP II
CA Spontaneously immortalized cell line
//
ID HELP II
AC CVCL_6D75
RX PubMed=2434329;
RX PubMed=6190961;
CC Breed/subspecies: C3H.
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_6D74 ! HELP I
CA Spontaneously immortalized cell line
//
ID HELP III
AC CVCL_6D76
RX PubMed=1711471;
RX PubMed=2434329;
CC Breed/subspecies: C3H.
OX NCBI_TaxID=10090; ! Mus musculus
CA Spontaneously immortalized cell line
//
ID HELP IV
AC CVCL_6D77
RX PubMed=2434329;
RX PubMed=3597519;
CC Breed/subspecies: C3H.
OX NCBI_TaxID=10090;! Mus musculus
CA Spontaneously immortalized cell line
//
ID HeNC2
AC CVCL_8601
RX PubMed=9039268;
CC Transformant: Recombinant retrovirus J2.
CC Breed/subspecies: C3H/HeN.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID Hep 3B2.1-7
AC CVCL_0326
SY Hep 3B2_1-7; Hep 3B2; HEP-3B2; HEP3B2; Hep-3B; HEP-3B; Hep 3B; Hep3B;HEP3B
DR BTO; BTO:0000972
DR BTO; BTO:0004116
DR CLO; CLO_0003702
DR CLO; CLO_0003703
DR CLO; CLO_0003710
DR EFO; EFO_0002205
DR MCCL; MCC:0000221
DR CLDB; cl1627
DR CLDB; cl1628
DR CLDB; cl1629
DR CLDB; cl1630
DR ATCC; HB-8064
DR BCRC; 60434
DR BCRJ; 0357
DR BioSample; SAMN03473193
DR CCLE; HEP3B217_LIVER
DR CCRID; 3111C0001CCC000376
DR CCRID; 3111C0002000000059
DR CCRID; 3131C0001000700106
DR CCRID; 3142C0001000000069
DR CGH-DB; 454-3
DR CGH-DB; 9069-4
DR Cosmic; 873401
DR Cosmic; 928140
DR Cosmic; 934549
DR Cosmic; 948066
DR Cosmic; 979729
DR Cosmic; 999851
DR Cosmic; 1019316
DR Cosmic; 1177682
DR Cosmic; 1351510
DR Cosmic; 1518225
DR Cosmic; 1628385
DR Cosmic; 2023864
DR Cosmic; 2162536
DR Cosmic; 2301557
DR Cosmic; 2321030
DR Cosmic-CLP; 1240147
DR DSMZ; ACC-93
DR ECACC; 86062703
DR GDSC; 1240147
DR GEO; GSM207050
DR GEO; GSM565879
DR GEO; GSM887078
DR GEO; GSM888148
DR GEO; GSM936759
DR GEO; GSM1374531
DR GEO; GSM1669879
DR IGRhCellID; Hep3B
DR IZSLER; BS TCL 78
DR KCB; KCB 200942YJ
DR KCLB; 88064
DR PRIDE; PXD000533
DR PRIDE; PXD000535
DR TKG; TKG 0291
DR TOKU-E; 1439
DR TOKU-E; 3574
RX Patent=US4393133;
RX PubMed=2439335;
RX PubMed=8050184;
RX PubMed=9290701;
RX PubMed=12029633;
RX PubMed=15767549;
RX PubMed=22460905;
RX PubMed=23505090;
RX PubMed=23887712;
RX PubMed=24116068;
RX PubMed=25574106;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.addexbio.com/productdetail?pid=45
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-106.html
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: JFCR45 cancer cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Characteristics: Has lost chromosome Y.
CC Doubling time: ~40-50 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; DSMZ; ECACC; KCLB; PubMed=24116068;PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 8
ST D13S317: 12,14
ST D16S539: 10
ST D18S51: 20
ST D19S433: 12.2,14
ST D21S11: 30,31
ST D2S1338: 21,25
ST D3S1358: 15
ST D5S818: 13
ST D7S820: 8,10
ST D8S1179: 12
ST FGA: 18
ST Penta D: 12,14
ST Penta E: 5,16
ST TH01: 6,7
ST TPOX: 9
ST vWA: 17
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Hep 40
AC CVCL_EI25
SY Hep-40; Hep40
DR Cosmic; 2321032
RX PubMed=7590653;
RX PubMed=25574106;
CC Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HEP G2ins
AC CVCL_HA60
SY HEPG2ins; HepG2ins
RX Patent=WO1995032740A1;
RX PubMed=7614254;
RX PubMed=12958175;
CC Transfected with: HGNC; 6081; INS.
DI NCIt; C3728; Hepatoblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0027 ! Hep-G2
SX Male
CA Cancer cell line
//
ID HEP G2ins/g
AC CVCL_HA61
SY HEPG2ins/g; HepG2ins/g
RX Patent=WO1995032740A1;
RX PubMed=9425444;
RX PubMed=12958175;
CC Characteristics: Synthesizes, stores and secretes insulin in a regulatedmanner when exposed to glucose in tissue culture.
CC Transfected with: HGNC; 6081; INS.
CC Transfected with: HGNC; 1006; SLC2A2.
DI NCIt; C3728; Hepatoblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_HA60 ! HEP G2ins
SX Male
CA Cancer cell line
//
ID HEp-2
AC CVCL_1906
SY Hep-2; HEP-2; Hep 2; Hep2; HEp2; HEP2; H.Ep.-2; H.Ep. #2; Hep II; HumanEpithelioma-2
DR BTO; BTO:0000976
DR CLO; CLO_0003706
DR CLO; CLO_0003707
DR CLO; CLO_0050927
DR EFO; EFO_0006438
DR CLDB; cl1646
DR CLDB; cl1647
DR CLDB; cl1649
DR CLDB; cl1650
DR CLDB; cl1653
DR CLDB; cl1654
DR CLDB; cl1655
DR ATCC; CCL-23
DR BCRJ; 0101
DR BioSample; SAMN03151706
DR CCLV; CCLV-RIE 0141
DR CCRID; 3111C0001CCC000068
DR CCRID; 3111C0002000000056
DR CCRID; 3131C0001000700021
DR CCRID; 3142C0001000000004
DR CCRID; 3142C0001000000614
DR ChEMBL-Cells; CHEMBL3307694
DR ChEMBL-Targets; CHEMBL614735
DR CLS; 300397/p694_Hep-2
DR Cosmic; 1339928
DR Cosmic; 1530739
DR Cosmic; 1969495
DR Cosmic; 2301559
DR ECACC; 86030501
DR GEO; GSM1374529
DR GEO; GSM1374530
DR IZSLER; BS TCL 23
DR KCLB; 10023
DR Lonza; 750
DR NCBI_Iran; C144
DR RCB; RCB1889
DR TKG; TKG 0403
DR TOKU-E; 1442
DR Wikidata; Q16554737
RX DOI=10.1007/978-1-4757-1647-4_13;
RX PubMed=566722;
RX PubMed=1246601;
RX PubMed=4203458;
RX PubMed=13209540;
RX PubMed=17254797;
RX PubMed=19941903;
RX PubMed=20143388;
RX PubMed=23925245;
RX PubMed=25485619;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-204.html
WW http://en.vircell.com/products/hep-2-cell-line/
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
WW https://es.wikipedia.org/wiki/C%C3%A9lulas_HEp-2
CC Problematic cell line: Contaminated. Shown to be a HeLa derivative(PubMed=566722, PubMed=1246601, PubMed=20143388). Was originally thought tooriginate from a laryngeal carcinoma.
CC Part of: KuDOS 95 cell line panel.
CC Transformant: NCBI_TaxID; 333761; Humanpapillomavirus type 18 (HPV18).
CC Omics: Deep RNAseq analysis.
CC Omics: Genome sequenced (low read coverage).
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; CLS; KCLB; PubMed=11416159; PubMed=17254797; RCB; TKG
ST Amelogenin: X
ST CSF1PO: 9,10
ST D13S317: 12,13.3 (ATCC; CLS; KCLB; PubMed=11416159; TKG)
ST D13S317: 12,14 (PubMed=17254797)
ST D13S317: 12 (RCB)
ST D16S539: 9,10
ST D18S51: 16 (PubMed=11416159)
ST D18S51: 15 (PubMed=17254797)
ST D21S11: 27,28 (PubMed=11416159)
ST D21S11: 26,27 (PubMed=17254797)
ST D3S1358: 15,18
ST D5S818: 11,12
ST D7S820: 8,12
ST D8S1179: 12,13
ST FGA: 18,21
ST Penta D: 8,15
ST Penta E: 7,17
ST TH01: 7
ST TPOX: 8,12
ST vWA: 16,18
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HEp-2 clone 2B
AC CVCL_2817
SY Hep2 (Clone 2B); Hep2 clone B
DR CLO; CLO_0003708
DR CLDB; cl1657
DR BioSample; SAMN03151705
DR ECACC; 85011412
RX PubMed=1246601;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Parent cell line (HEp-2) has beenshown to be a HeLa derivative (PubMed=1246601, PubMed=20143388).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1906 ! HEp-2
SX Female
CA Cancer cell line
//
ID Hep-2 TPFR
AC CVCL_GZ00
RX PubMed=25962396;
CC Problematic cell line: Contaminated. Parent cell line (HEp-2) has beenshown to be a HeLa derivative (PubMed=1246601, PubMed=20143388).
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
CC Selected for resistance to: ChEBI; CHEBI:4672; Docetaxel anhydrous(Taxotere).
CC Selected for resistance to: ChEBI; CHEBI:46345; 5-fluorouracil (5-FU).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1906 ! HEp-2
SX Female
CA Cancer cell line
您正在向 biovector.net 发送关于产品 细胞株Cell Lines 29-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心 的询问
- 公告/新闻
